The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Deadlines:
- Letter of Intent: 30 days prior to the application due date
- Application Due Date(s): March 10, 2025; Aug 12, 2025; March 10, 2026; Aug 5, 2026; March 10, 2027; Aug 11, 2027
- AIDS Application Due Date(s): March 10, 2025; Aug 12, 2025; March 10, 2026; Aug 5, 2026; March 10, 2027; Aug 11, 2027
PAR-25-101 Expiration Date: August 12, 2027
The combined budget for direct costs for the two year project period may not exceed $275,000. No more than $150,000 in direct costs may be requested in any single year.